Diabetes, Dementia, and Aging at Home

糖尿病、痴呆症和家庭老龄化

基本信息

项目摘要

PROJECT SUMMARY Managing diabetes may be a significant barrier to aging at home for older adults, especially for those with Alzheimer’s disease or related dementias (ADRD). Over 40% percent of low-income older adults with Medicare and Medicaid have diabetes, but there is limited access to Medicaid home-and-community-based services (HCBS) that can assist with daily tasks like insulin injections, meal preparation, and monitoring glucose levels. Even though 25-40% of patients with dementia also have diabetes, little is known about diabetes management in this population. Without family members or other caregivers to assist, low-income older adults with diabetes may face unnecessary hospitalizations for diabetes and nursing home entry. Hypoglycemia, which can lead to falls, injuries, and loss of consciousness, is a large health risk for older adults with diabetes, especially if they are black, use insulin, or have dementia. Such issues are particularly concerning in the Southeast due to the region’s high prevalence of diabetes and ADRD. The Southern Community Cohort Study, a prospective cohort study of low-income white and black Southeastern residents that includes over 12,000 participants age 65 and above with diabetes, provides a unique opportunity to understand diabetes-related barriers to living at home. By linking survey data to claims data, this study will examine which factors, including dementia and limited social support, predict initial use of Medicaid HCBS and nursing home services. Over a fifteen-year period, the study will analyze whether more generous coverage of Medicaid HCBS benefits is associated with changes in nursing home entry, inpatient and emergency room use, and treatment for hypoglycemia. To better understand what factors may prevent older adults from using simpler insulin regimens that may lower their risk for hypoglycemia, the study will examine whether lower out-of-pocket costs for simpler insulin options are associated with greater use of these drugs, and whether these associations differ for older adults with dementia or limited social support who may have more difficulty navigating drug benefits. Finally, the study will assess whether better coverage of simpler insulin options is associated with lower risk of hospitalizations, emergency room visits, treatment for hypoglycemia, and nursing home entry. The results will provide novel evidence about how Medicare and Medicaid policies may be able to address the needs of older adults with diabetes as they age at home and prevent poor health outcomes, especially for those with dementia or limited social support.
项目总结 管理糖尿病可能是老年人在家中衰老的一个重要障碍,特别是对那些 患有阿尔茨海默病或相关痴呆症(ADRD)。超过40%的低收入老年人患有 Medicare和Medicaid患有糖尿病,但获得以家庭和社区为基础的Medicaid的机会有限 可协助完成胰岛素注射、餐饮准备和监测等日常任务的服务(HCBS) 血糖水平。尽管25%-40%的痴呆症患者也患有糖尿病,但人们对此知之甚少 这一人群中的糖尿病管理。没有家人或其他照顾者的帮助,低收入者 患有糖尿病的老年人可能会因为糖尿病而面临不必要的住院治疗和疗养院的进入。 低血糖会导致跌倒、受伤和意识丧失,对老年人来说是一个很大的健康风险。 糖尿病患者,尤其是黑人、使用胰岛素或患有痴呆症的患者。 这类问题在东南部尤其令人担忧,因为该地区有很高的 糖尿病和ADRD。南方社区队列研究,低收入白人的前瞻性队列研究 以及东南部黑人居民,其中包括超过12000名65岁及以上的糖尿病患者, 为了解与糖尿病相关的居家障碍提供了一个独特的机会。通过链接调查数据 对于索赔数据,这项研究将检验哪些因素,包括痴呆症和有限的社会支持,可以预测 初步使用医疗补助、医疗补助、家庭保健和养老院服务。在15年的时间里,这项研究将分析 更慷慨的医疗补助和医疗补助福利覆盖范围是否与疗养院的变化有关 入院、住院和急诊室使用,以及低血糖治疗。为了更好地了解哪些因素 可能会阻止老年人使用简单的胰岛素方案,这可能会降低他们患低血糖的风险, 研究将检验更简单的胰岛素选择的自付成本较低是否与更多的使用相关 以及这些关联对于患有痴呆症或社会支持有限的老年人是否有所不同 他们可能在浏览药品福利方面有更大的困难。最后,这项研究将评估更好的覆盖范围 更简单的胰岛素选择与较低的住院、急诊室就诊、 低血糖,疗养院入院。这一结果将为医疗保险和医疗保险如何 医疗补助政策可能能够满足患有糖尿病的老年人的需求,因为他们在家和 预防不良的健康结果,特别是对于痴呆症患者或社会支持有限的人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Margaret Keohane其他文献

Laura Margaret Keohane的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Margaret Keohane', 18)}}的其他基金

Diabetes, Dementia, and Aging at Home
糖尿病、痴呆症和家庭老龄化
  • 批准号:
    10040573
  • 财政年份:
    2020
  • 资助金额:
    $ 41.54万
  • 项目类别:
Diabetes, Dementia, and Aging at Home
糖尿病、痴呆症和家庭老龄化
  • 批准号:
    10652425
  • 财政年份:
    2020
  • 资助金额:
    $ 41.54万
  • 项目类别:
Routine Care during COVID-19 pandemic for Low-income Older Adults with Diabetes and Dementia
COVID-19 大流行期间患有糖尿病和痴呆症的低收入老年人的常规护理
  • 批准号:
    10307304
  • 财政年份:
    2020
  • 资助金额:
    $ 41.54万
  • 项目类别:
Diabetes, Dementia, and Aging at Home
糖尿病、痴呆症和家庭老龄化
  • 批准号:
    10249973
  • 财政年份:
    2020
  • 资助金额:
    $ 41.54万
  • 项目类别:
Quality of Care for Dual-Eligible Beneficiaries in Managed Care Plans
管理式护理计划中双重资格受益人的护理质量
  • 批准号:
    10382395
  • 财政年份:
    2018
  • 资助金额:
    $ 41.54万
  • 项目类别:
Quality of Care for Dual-Eligible Beneficiaries in Managed Care Plans
管理式护理计划中双重资格受益人的护理质量
  • 批准号:
    9915835
  • 财政年份:
    2018
  • 资助金额:
    $ 41.54万
  • 项目类别:
The Impact of Medicare Hospitalizations and Deductibles on Medicaid Enrollment
医疗保险住院和免赔额对医疗补助登记的影响
  • 批准号:
    8707034
  • 财政年份:
    2014
  • 资助金额:
    $ 41.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了